These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 4565370

  • 21. [Factor XIII, its physiological significance (a review of the literature)].
    Baluda VP, Zhukova NA.
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):34-40. PubMed ID: 4271843
    [No Abstract] [Full Text] [Related]

  • 22. Titration of the acceptor cross-linking sites in fibrin.
    Lorand L, Chenoweth D, Gray A.
    Ann N Y Acad Sci; 1972 Dec 08; 202():155-71. PubMed ID: 4508920
    [No Abstract] [Full Text] [Related]

  • 23. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation.
    Lorand L, Urayama T, De Kiewiet JW, Nossel HL.
    J Clin Invest; 1969 Jun 08; 48(6):1054-64. PubMed ID: 4977030
    [Abstract] [Full Text] [Related]

  • 24. Equilibria in the fibrinogen--fibrin conversion. 8. Polymerization of acceptor-modified fibrin monomer.
    Endres GF, Scheraga HA.
    Biochemistry; 1968 Dec 08; 7(12):4219-26. PubMed ID: 5750166
    [No Abstract] [Full Text] [Related]

  • 25. [Fibrin stabilizing factor].
    Konishi K, Takagi T.
    Tanpakushitsu Kakusan Koso; 1970 Dec 08; 15(14):1441-51. PubMed ID: 5530020
    [No Abstract] [Full Text] [Related]

  • 26. Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta.
    Takahashi N, Takahashi Y, Putnam FW.
    Proc Natl Acad Sci U S A; 1986 Nov 08; 83(21):8019-23. PubMed ID: 2877456
    [Abstract] [Full Text] [Related]

  • 27. Human fibrinogen free of factor XIII: the pursuit of biological zero.
    Finlayson JS.
    Ann N Y Acad Sci; 1972 Dec 08; 202():149-54. PubMed ID: 4629549
    [No Abstract] [Full Text] [Related]

  • 28. Documentation of the plasma factor XIII deficiency in man.
    Duckert F.
    Ann N Y Acad Sci; 1972 Dec 08; 202():190-9. PubMed ID: 4508922
    [No Abstract] [Full Text] [Related]

  • 29. ACTIVATION OF THE FIBRIN STABILIZING FACTOR OF PLASMA BY THROMBIN.
    LORAND L, KONISHI K.
    Arch Biochem Biophys; 1964 Apr 08; 105():58-67. PubMed ID: 14165504
    [No Abstract] [Full Text] [Related]

  • 30. Rheology of fibrin clots. II. Linear viscoelastic behavior in shear creep.
    Gerth C, Roberts WW, Ferry JD.
    Biophys Chem; 1974 Oct 08; 2(3):208-17. PubMed ID: 4474029
    [No Abstract] [Full Text] [Related]

  • 31. Factor XIII (fibrin-stabilizing factor).
    Lorand L, Credo RB, Janus TJ.
    Methods Enzymol; 1981 Oct 08; 80 Pt C():333-41. PubMed ID: 7341914
    [No Abstract] [Full Text] [Related]

  • 32. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
    Pitkänen HH, Jouppila A, Lemponen M, Ilmakunnas M, Ahonen J, Lassila R.
    Thromb Res; 2017 Jan 08; 149():56-61. PubMed ID: 27902939
    [Abstract] [Full Text] [Related]

  • 33. Activation of blood coagulation factor XIII.
    Lorand L.
    Ann N Y Acad Sci; 1986 Jan 08; 485():144-58. PubMed ID: 3471146
    [No Abstract] [Full Text] [Related]

  • 34. Tissue transamidases, fibrin stabilization and clot lysis.
    Tyler HM.
    Ann N Y Acad Sci; 1972 Dec 08; 202():273-85. PubMed ID: 4565369
    [No Abstract] [Full Text] [Related]

  • 35. Kinetics of transamidating enzymes. Production of thiol in the reactions of thiol esters with fibrinoligase.
    Curtis CG, Stenberg P, Brown KL, Baron A, Chen K, Gray A, Simpson I, Lorand L.
    Biochemistry; 1974 Jul 30; 13(16):3257-62. PubMed ID: 4841063
    [No Abstract] [Full Text] [Related]

  • 36. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS, Miraglia CC, Rickles FR, Shuman MA.
    J Clin Invest; 1985 May 30; 75(5):1463-70. PubMed ID: 2860124
    [Abstract] [Full Text] [Related]

  • 37. Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen.
    Shen L, Lorand L.
    J Clin Invest; 1983 May 30; 71(5):1336-41. PubMed ID: 6853717
    [Abstract] [Full Text] [Related]

  • 38. Fibrin cross-linking in congenital factor XIII deficiency.
    Rodeghiero F, Barbui T.
    J Clin Pathol; 1980 May 30; 33(5):434-7. PubMed ID: 7400341
    [Abstract] [Full Text] [Related]

  • 39. Purification and subunit structure of human plasma and platelet fibrin-stabilizing factor.
    Schwartz ML, Pizzo SV, Hill RL, McKee PA, Bird RM.
    J Lab Clin Med; 1971 Nov 30; 78(5):848. PubMed ID: 5128900
    [No Abstract] [Full Text] [Related]

  • 40. Generation and mechanism of action of a potent inhibitor of factor XIII function.
    Reed GL, Lukacova D.
    Thromb Haemost; 1995 Aug 30; 74(2):680-5. PubMed ID: 8585006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.